A Multinational, Phase 2, Randomised, Adaptive Protocol to Evaluate Immunogenicity and Reactogenicity of Different COVID-19 Vaccines Administration in Older Adults (≥75) Already Vaccinated Against SARS-CoV-2
Lead: Oliver Cornely, Institution/Sponsor: UHC, Germany
Details:
https://clinicaltrials.gov/ct2/show/NCT05160766?cond=Covat+aged&draw=2&rank=1
Publications: